Featured News
More News
Dr. David Maahs will co-direct the NIH national diabetes training program, Diabdocs, to help endocrinologists build their expertise in type 1 diabetes research and treatment
Stanford Medicine recently became the national center for a program to improve the diversity and increase the number of physician-scientists who are experts in Type 1 diabetes.
Dr. Karl Deisseroth Receives the 2023 Japan Prize!
On January 24, 2023, Dr. Karl Deisseroth , the 2018 Kyoto Prize laureate in Advanced Technology, was selected as a recipient of the “Japan Prize” in Life Sciences. Many congratulations on this prestigious recognition!
Stanford Medicine researchers including Dr. Michael Snyder measure thousands of molecules from a single drop of blood
Using a new technique called multi-omic microsampling, Stanford Medicine researchers can measure thousands of protein, fat and metabolic molecules from a single drop of blood.
Stanford Medicine scientists pinpoint COVID-19 virus’s entry and exit ports inside our noses
A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.
‘Gentle’ islet cell transplant cures mice of diabetes with few side effects, Stanford Medicine researchers (Dr. Seung Kim) say
A technique developed at Stanford Medicine allows mice with diabetes to accept unmatched islet cells and durably restores blood sugar control without immunosuppression or graft-versus-host disease.
Following events at the ADA Scientific Sessions in June, a number of concerns raised regarding the ADA's professional section remain unresolved. As a result, a boycott of ADA activities has been initiated by leading figures in diabetes research. The text below includes relevant hyperlinks with further information. Those who wish to review the petition and consider whether to sign it may do so at the links provided. This information is being shared for member awareness.